1174P RESUNET (GETNE-2016-01): A phase II study to evaluate...

Annals of Oncology 2020 / 09 Vol. 31

1174P RESUNET (GETNE-2016-01): A phase II study to evaluate the efficacy and safety of the rechallenge with sunitinib in G1/G2 pancreatic neuroendocrine tumours (pNET). A Spanish Task Force Group in neuroendocrine and endocrine tumours (GETNE) study

Grande, E., Espinosa-Olarte, P., Serrano, R., Jimenez, P., Alonso, T., Benavent, M., Castillón, J. Capdevila, Lacasta, A., Tur, R. Yaya, Carmona, A., Gallegos, I., Rodríguez, R.M., Trujillo, A.O. Ca
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1387
Date:
September, 2020
File:
PDF, 122 KB
2020
Conversion to is in progress
Conversion to is failed